Menu
 

Search abstracts


Pk/pd evaluation of protein binding of ceftriaxone and levofloxacin in seriously ill patients

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Poster
  • By: SCOULAR, Sarah (University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Clinical Pharmacy)
  • Co-author(s): Sarah Scoular: Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, United States
    Ashley Hall
    Sanjana Rao: University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, ;, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, United States
    Scott Mueller: Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, United States
    Ty Kiser: Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, United States
    Doug Fish: Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, United States
  • Abstract:

    Background

    Protein deficiency in seriously ill patients may lead to increased unbound serum concentrations of highly protein bound antibiotics potentially leading to improved clinical outcomes.

    Methods

    Patients ≥18 years of age with creatinine clearance ≥50 ml/minute were prospectively enrolled into PK studies of ceftriaxone (CRO) and levofloxacin

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 13 May 2019

FIP Congresses